Sexually transmitted diseases and infections

Hepatitis B Diagnostic Tests Market: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)

Retrieved on: 
Wednesday, June 13, 2018
Medicine, Cancer, Microbiology, RTT, Infectious causes of cancer, Viral diseases, Healthcare-associated infections, Sexually transmitted diseases and infections, Hepatitis, Infection, HCV in children and pregnancy, Refugee health

As per the data provided by WHO, an estimated 257 million people are living with hepatitis B viral infection.

Key Points: 
  • As per the data provided by WHO, an estimated 257 million people are living with hepatitis B viral infection.
  • The prevalence of hepatitis B is highest in the Western Pacific and African regions where 6.2% and 6.1% respectively of the adult population is infected.
  • It is estimated that 80-90% of the infants infected with hepatitis B during first year of life develop chronic infections.
  • There is an increased prevalence of hepatitis B due to the exploding urbanization and environmental changes due to a changing lifestyle.

Roche to showcase new solutions to consolidate automated molecular testing, microbiology topics from industry experts at ASM Microbe 2018

Retrieved on: 
Thursday, June 7, 2018
Bacteria, Medicine, Mycoplasma, Infectious causes of cancer, Sexually transmitted diseases and infections, Microbiology, Infertility, Cobas, Methicillin-resistant Staphylococcus aureus

Roche is also highlighting the addition of its recently cleared cobas Factor II and Factor V test to the menu for its automated cobas 4800 system.

Key Points: 
  • Roche is also highlighting the addition of its recently cleared cobas Factor II and Factor V test to the menu for its automated cobas 4800 system.
  • The addition to the menu allows labs to consolidate genomics, oncology and microbiology testing onto a single platform.
  • Topics include C. difficile testing, MRSA screening, the role of mycoplasma genitalium in sexual health management, healthcare IT, automating LDTs, molecular HSV testing and more.
  • Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Cytomegalovirus (CMV) & Herpes Simplex Virus (HSV) Tests - In Vitro Diagnostics Market Analysis and Forecast Model

Retrieved on: 
Tuesday, May 22, 2018
Virology, Viral diseases, Sexually transmitted diseases and infections, Microbiology, Medicine, RTT, Betaherpesvirinae, Cytomegalovirus, Herpes, Herpes simplex virus, HSV, Herpes simplex

Cytomegalovirus(CMV) & Herpes Simplex Virus (HSV) Tests - In Vitro Diagnostics Market Analysis and Forecast Model is built to better visualize quantitative market trends of Cytomegalovirus(CMV) & Herpes Simplex Virus (HSV) Tests within the In Vitro Diagnostics market.

Key Points: 
  • Cytomegalovirus(CMV) & Herpes Simplex Virus (HSV) Tests - In Vitro Diagnostics Market Analysis and Forecast Model is built to better visualize quantitative market trends of Cytomegalovirus(CMV) & Herpes Simplex Virus (HSV) Tests within the In Vitro Diagnostics market.
  • Wherein, Herpes Simplex Virus (HSV) test is done for diagnosing the Herpes Simplex Virus (HSV).HSV has two serotypes, HSV1 & HSV2.
  • - Annualized total Cytomegalovirus(CMV) & Herpes Simplex Virus (HSV) Tests market revenue by segment and market outlooks from 2005-2024.
  • - Develop business strategies by understanding the trends shaping and driving the Cytomegalovirus(CMV) & Herpes Simplex Virus (HSV) Tests market.

Chlamydia Trichomatis Diagnostic Test Kits - In Vitro Diagnostics Market Analysis and Forecast Model

Retrieved on: 
Tuesday, May 22, 2018
Chlamydiae, Chlamydia infections, Sexually transmitted diseases and infections, RTT, Market analysis, Culture

Chlamydia Trichomatis Diagnostic Test Kits - In Vitro Diagnostics Market Analysis and Forecast Model is built to better visualize quantitative market trends of Chlamydia Trichomatis Diagnostic Test Kits within the In Vitro Diagnostics market.

Key Points: 
  • Chlamydia Trichomatis Diagnostic Test Kits - In Vitro Diagnostics Market Analysis and Forecast Model is built to better visualize quantitative market trends of Chlamydia Trichomatis Diagnostic Test Kits within the In Vitro Diagnostics market.
  • - Annualized total Chlamydia trichomatis Diagnostic Test Kits market revenue by segment and market outlooks from 2005-2024.
  • - Develop business strategies by understanding the trends shaping and driving the Chlamydia Trichomatis Diagnostic Test Kits market.
  • - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Chlamydia Trichomatis Diagnostic Test Kits market in the future.

Global Cervical Cancer Epidemiology and Patient Flow Analysis 2017-2026

Retrieved on: 
Thursday, April 19, 2018
Cancer, Infectious causes of cancer, RTT, Gynaecological cancer, Sexually transmitted diseases and infections, Carcinogenesis, Cervical cancer, Epidemiology of cancer, Gynecologic cancer disparities in the United States, Elizabeth Stern

The "Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
  • The research provides insights into Cervical Cancer epidemiology, Cervical Cancer diagnosed patients, and Cervical Cancer treatment rate for US, Japan, and EU5 countries.
  • The research measures key indicators including prevalence of Cervical Cancer derived from epidemiological analysis, patients diagnosed with Cervical Cancer, and patients treated with a drug therapy.
  • The research provides estimates and forecasts of Cervical Cancer prevalence, Cervical Cancer diagnosis rate, and Cervical Cancer treatment rate for the period 2017 - 2026.